# Phase I open-label, ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies: Dose selection for combination with PD-1 blockade.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-i-open-label-ascending-dose-trial-of-agen1884-an-anti-ctla-4-monoclonal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Breelyn A. Wilky,Priya Kumthekar,Robert Wesolowski,Jimmy J. Hwang,Steven I. Park,Igor Proscurshim,Guojun Yuan,Christopher D. Dupont,Olga Shebanova,Jean-Marie Cuillerot,Edward Dow,Jeffrey J. Raizer,Carleen Gentry,Ainsley Ross,Elise E. Drouin,Nicholas S. Wilson,John M. Goldberg,Jennifer S. Buell,Robert B. Stein |
| Citations | 2 |
| DOI | 10.1200/jco.2018.36.15_suppl.3075 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2891923852 |
| Type | conference-abstract |
| Year | 2018 |

## Paper authors

- [Ainsley Ross](https://scholariq.org/researchers/ainsley-ross/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.